316 related articles for article (PubMed ID: 38724526)
21. Clinical trial links oncolytic immunoactivation to survival in glioblastoma.
Ling AL; Solomon IH; Landivar AM; Nakashima H; Woods JK; Santos A; Masud N; Fell G; Mo X; Yilmaz AS; Grant J; Zhang A; Bernstock JD; Torio E; Ito H; Liu J; Shono N; Nowicki MO; Triggs D; Halloran P; Piranlioglu R; Soni H; Stopa B; Bi WL; Peruzzi P; Chen E; Malinowski SW; Prabhu MC; Zeng Y; Carlisle A; Rodig SJ; Wen PY; Lee EQ; Nayak L; Chukwueke U; Gonzalez Castro LN; Dumont SD; Batchelor T; Kittelberger K; Tikhonova E; Miheecheva N; Tabakov D; Shin N; Gorbacheva A; Shumskiy A; Frenkel F; Aguilar-Cordova E; Aguilar LK; Krisky D; Wechuck J; Manzanera A; Matheny C; Tak PP; Barone F; Kovarsky D; Tirosh I; Suvà ML; Wucherpfennig KW; Ligon K; Reardon DA; Chiocca EA
Nature; 2023 Nov; 623(7985):157-166. PubMed ID: 37853118
[TBL] [Abstract][Full Text] [Related]
22. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016-2020.
Ostrom QT; Price M; Neff C; Cioffi G; Waite KA; Kruchko C; Barnholtz-Sloan JS
Neuro Oncol; 2023 Oct; 25(12 Suppl 2):iv1-iv99. PubMed ID: 37793125
[TBL] [Abstract][Full Text] [Related]
23. A H3K27M-targeted vaccine in adults with diffuse midline glioma.
Grassl N; Poschke I; Lindner K; Bunse L; Mildenberger I; Boschert T; Jähne K; Green EW; Hülsmeyer I; Jünger S; Kessler T; Suwala AK; Eisele P; Breckwoldt MO; Vajkoczy P; Grauer OM; Herrlinger U; Tonn JC; Denk M; Sahm F; Bendszus M; von Deimling A; Winkler F; Wick W; Platten M; Sahm K
Nat Med; 2023 Oct; 29(10):2586-2592. PubMed ID: 37735561
[TBL] [Abstract][Full Text] [Related]
24. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization.
Rahman R; Trippa L; Lee EQ; Arrillaga-Romany I; Fell G; Touat M; McCluskey C; Wiley J; Gaffey S; Drappatz J; Welch MR; Galanis E; Ahluwalia MS; Colman H; Nabors LB; Hepel J; Elinzano H; Schiff D; Chukwueke UN; Beroukhim R; Nayak L; McFaline-Figueroa JR; Batchelor TT; Rinne ML; Kaley TJ; Lu-Emerson C; Mellinghoff IK; Bi WL; Arnaout O; Peruzzi PP; Haas-Kogan D; Tanguturi S; Cagney D; Aizer A; Doherty L; Lavallee M; Fisher-Longden B; Dowling S; Geduldig J; Watkinson F; Pisano W; Malinowski S; Ramkissoon S; Santagata S; Meredith DM; Chiocca EA; Reardon DA; Alexander BM; Ligon KL; Wen PY
J Clin Oncol; 2023 Dec; 41(36):5524-5535. PubMed ID: 37722087
[TBL] [Abstract][Full Text] [Related]
25. Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current management.
Avila EK; Tobochnik S; Inati SK; Koekkoek JAF; McKhann GM; Riviello JJ; Rudà R; Schiff D; Tatum WO; Templer JW; Weller M; Wen PY
Neuro Oncol; 2024 Jan; 26(1):7-24. PubMed ID: 37699031
[TBL] [Abstract][Full Text] [Related]
26. Combined cytotoxic and immune-stimulatory gene therapy for primary adult high-grade glioma: a phase 1, first-in-human trial.
Umemura Y; Orringer D; Junck L; Varela ML; West MEJ; Faisal SM; Comba A; Heth J; Sagher O; Leung D; Mammoser A; Hervey-Jumper S; Zamler D; Yadav VN; Dunn P; Al-Holou W; Hollon T; Kim MM; Wahl DR; Camelo-Piragua S; Lieberman AP; Venneti S; McKeever P; Lawrence T; Kurokawa R; Sagher K; Altshuler D; Zhao L; Muraszko K; Castro MG; Lowenstein PR
Lancet Oncol; 2023 Sep; 24(9):1042-1052. PubMed ID: 37657463
[TBL] [Abstract][Full Text] [Related]
27. The coming of age of liquid biopsy in neuro-oncology.
Berzero G; Pieri V; Mortini P; Filippi M; Finocchiaro G
Brain; 2023 Oct; 146(10):4015-4024. PubMed ID: 37289981
[TBL] [Abstract][Full Text] [Related]
28. Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline.
Sahm F; Brandner S; Bertero L; Capper D; French PJ; Figarella-Branger D; Giangaspero F; Haberler C; Hegi ME; Kristensen BW; Kurian KM; Preusser M; Tops BBJ; van den Bent M; Wick W; Reifenberger G; Wesseling P
Neuro Oncol; 2023 Oct; 25(10):1731-1749. PubMed ID: 37279174
[TBL] [Abstract][Full Text] [Related]
29. Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures.
Pe M; Alanya A; Falk RS; Amdal CD; Bjordal K; Chang J; Cislo P; Coens C; Dirven L; Speck RM; Fitzgerald K; Galinsky J; Giesinger JM; Holzner B; Le Cessie S; O'Connor D; Oliver K; Pawar V; Quinten C; Schlichting M; Ren J; Roychoudhury S; Taphoorn MJB; Velikova G; Wintner LM; Griebsch I; Bottomley A;
Lancet Oncol; 2023 Jun; 24(6):e270-e283. PubMed ID: 37269858
[TBL] [Abstract][Full Text] [Related]
30. Significant increase of high-risk chromosome 1q gain and 6q loss at recurrence in posterior fossa group A ependymoma: A multicenter study.
Donson AM; Bertrand KC; Riemondy KA; Gao D; Zhuang Y; Sanford B; Norris GA; Chapman RJ; Fu R; Willard N; Griesinger AM; Ribeiro de Sousa G; Amani V; Grimaldo E; Hankinson TC; Booker F; Sill M; Grundy RG; Pajtler KW; Ellison DW; Foreman NK; Ritzmann TA
Neuro Oncol; 2023 Oct; 25(10):1854-1867. PubMed ID: 37246777
[TBL] [Abstract][Full Text] [Related]
31. Targeted delivery of tumor necrosis factor in combination with CCNU induces a T cell-dependent regression of glioblastoma.
Look T; Puca E; Bühler M; Kirschenbaum D; De Luca R; Stucchi R; Ravazza D; Di Nitto C; Roth P; Katzenelenbogen Y; Weiner A; Rindlisbacher L; Becher B; Amit I; Weller M; Neri D; Hemmerle T; Weiss T
Sci Transl Med; 2023 May; 15(697):eadf2281. PubMed ID: 37224228
[TBL] [Abstract][Full Text] [Related]
32. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Nassiri F; Patil V; Yefet LS; Singh O; Liu J; Dang RMA; Yamaguchi TN; Daras M; Cloughesy TF; Colman H; Kumthekar PU; Chen CC; Aiken R; Groves MD; Ong SS; Ramakrishna R; Vogelbaum MA; Khagi S; Kaley T; Melear JM; Peereboom DM; Rodriguez A; Yankelevich M; Nair SG; Puduvalli VK; Aldape K; Gao A; López-Janeiro Á; de Andrea CE; Alonso MM; Boutros P; Robbins J; Mason WP; Sonabend AM; Stupp R; Fueyo J; Gomez-Manzano C; Lang FF; Zadeh G
Nat Med; 2023 Jun; 29(6):1370-1378. PubMed ID: 37188783
[TBL] [Abstract][Full Text] [Related]
33. Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial.
Sonabend AM; Gould A; Amidei C; Ward R; Schmidt KA; Zhang DY; Gomez C; Bebawy JF; Liu BP; Bouchoux G; Desseaux C; Helenowski IB; Lukas RV; Dixit K; Kumthekar P; Arrieta VA; Lesniak MS; Carpentier A; Zhang H; Muzzio M; Canney M; Stupp R
Lancet Oncol; 2023 May; 24(5):509-522. PubMed ID: 37142373
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency.
Das A; Tabori U; Sambira Nahum LC; Collins NB; Deyell R; Dvir R; Faure-Conter C; Hassall TE; Minturn JE; Edwards M; Brookes E; Bianchi V; Levine A; Stone SC; Sudhaman S; Sanchez Ramirez S; Ercan AB; Stengs L; Chung J; Negm L; Getz G; Maruvka YE; Ertl-Wagner B; Ohashi PS; Pugh T; Hawkins C; Bouffet E; Morgenstern DA
Clin Cancer Res; 2023 Dec; 29(23):4770-4783. PubMed ID: 37126021
[TBL] [Abstract][Full Text] [Related]
35. The genomic landscape of familial glioma.
Choi DJ; Armstrong G; Lozzi B; Vijayaraghavan P; Plon SE; Wong TC; Boerwinkle E; Muzny DM; Chen HC; Gibbs RA; Ostrom QT; Melin B; Deneen B; Bondy ML; ; ; Bainbridge MN; Amos CI; Barnholtz-Sloan JS; Bernstein JL; Claus EB; Houlston RS; Il'yasova D; Jenkins RB; Johansen C; Lachance D; Lai R; Melin BS; Merrell RT; Olson SH; Sadetzki S; Schildkraut J; Shete S; Ambrose JC; Arumugam P; Bevers R; Bleda M; Boardman-Pretty F; Boustred CR; Brittain H; Brown MA; Caulfield MJ; Chan GC; Giess A; Griffin JN; Hamblin A; Henderson S; Hubbard TJP; Jackson R; Jones LJ; Kasperaviciute D; Kayikci M; Kousathanas A; Lahnstein L; Lakey A; Leigh SEA; Leong IUS; Lopez FJ; Maleady-Crowe F; McEntagart M; Minneci F; Mitchell J; Moutsianas L; Mueller M; Murugaesu N; Need AC; O'Donovan P; Odhams CA; Patch C; Perez-Gil D; Pereira MB; Pullinger J; Rahim T; Rendon A; Rogers T; Savage K; Sawant K; Scott RH; Siddiq A; Sieghart A; Smith SC; Sosinsky A; Stuckey A; Tanguy M; Taylor Tavares AL; Thomas ERA; Thompson SR; Tucci A; Welland MJ; Williams E; Witkowska K; Wood SM; Zarowiecki M
Sci Adv; 2023 Apr; 9(17):eade2675. PubMed ID: 37115922
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology, biology, and management of venous thromboembolism in gliomas: An interdisciplinary review.
Jo J; Diaz M; Horbinski C; Mackman N; Bagley S; Broekman M; Rak J; Perry J; Pabinger I; Key NS; Schiff D
Neuro Oncol; 2023 Aug; 25(8):1381-1394. PubMed ID: 37100086
[TBL] [Abstract][Full Text] [Related]
37. Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging.
Hollon T; Jiang C; Chowdury A; Nasir-Moin M; Kondepudi A; Aabedi A; Adapa A; Al-Holou W; Heth J; Sagher O; Lowenstein P; Castro M; Wadiura LI; Widhalm G; Neuschmelting V; Reinecke D; von Spreckelsen N; Berger MS; Hervey-Jumper SL; Golfinos JG; Snuderl M; Camelo-Piragua S; Freudiger C; Lee H; Orringer DA
Nat Med; 2023 Apr; 29(4):828-832. PubMed ID: 36959422
[TBL] [Abstract][Full Text] [Related]
38. NCCN Guidelines® Insights: Central Nervous System Cancers, Version 2.2022.
Horbinski C; Nabors LB; Portnow J; Baehring J; Bhatia A; Bloch O; Brem S; Butowski N; Cannon DM; Chao S; Chheda MG; Fabiano AJ; Forsyth P; Gigilio P; Hattangadi-Gluth J; Holdhoff M; Junck L; Kaley T; Merrell R; Mrugala MM; Nagpal S; Nedzi LA; Nevel K; Nghiemphu PL; Parney I; Patel TR; Peters K; Puduvalli VK; Rockhill J; Rusthoven C; Shonka N; Swinnen LJ; Weiss S; Wen PY; Willmarth NE; Bergman MA; Darlow S
J Natl Compr Canc Netw; 2023 Jan; 21(1):12-20. PubMed ID: 36634606
[TBL] [Abstract][Full Text] [Related]
39. Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
Hervey-Jumper SL; Zhang Y; Phillips JJ; Morshed RA; Young JS; McCoy L; Lafontaine M; Luks T; Ammanuel S; Kakaizada S; Egladyous A; Gogos A; Villanueva-Meyer J; Shai A; Warrier G; Rice T; Crane J; Wrensch M; Wiencke JK; Daras M; Oberheim Bush NA; Taylor JW; Butowski N; Clarke J; Chang S; Chang E; Aghi M; Theodosopoulos P; McDermott M; Jakola AS; Kavouridis VK; Nawabi N; Solheim O; Smith T; Berger MS; Molinaro AM
J Clin Oncol; 2023 Apr; 41(11):2029-2042. PubMed ID: 36599113
[TBL] [Abstract][Full Text] [Related]
40. Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033.
Kros JM; Rushing E; Uwimana AL; Hernández-Laín A; Michotte A; Al-Hussaini M; Bielle F; Mawrin C; Marucci G; Tesileanu CMS; Stupp R; Baumert B; van den Bent M; French PJ; Gorlia T
Neuro Oncol; 2023 Aug; 25(8):1443-1449. PubMed ID: 36571817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
